The National Pharmaceutical Pricing Authority (NPPA) has revised the ceiling price of 18 more drugs.
The latest move will mean reduction in price of up to 23 per cent for the 18 drugs.
Of the 18, 10 drugs have been part of the National List of Essential Medicines (NLEM), 2011 and 2015.
Another eight are drugs that are coming under price control for the first time, as they have now been included in the list of essential medicines.
The drugs that have come under price revision now are for chemotherapy, treating malaria and epilepsy, among others.
In July, 123 medicines were brought under drug price control.
A total of around 900 drugs are part of the NLEM, 2015.
